A Pilot Study Evaluating a Novel Magneto-Fluidic System for Ultra-High Throughput Detection of Circulating Tumor Cells in Patients with Metastatic and Loco-regional Urothelial Bladder Cancer IUSCC-0552



Study Overview

The purpose of this study is to determine if cancer cells in blood can be reliably detected in bladder cancer patients using a new blood test known as a "liquid biopsy."


Study Description

The purpose of this study is to test and optimize this magneto-fluidic system we have developed to capture circulating tumor cells from samples of patients with advanced urothelial bladder cancer, and potentially applu this system to an earlier clinical stage cohort to predict advanced pathology.

Additional Information:

Participants will not be paid for their participation.



Research Study Identifier: TX5848
ClinicalTrials.gov Identifier: NCT1601654610
Principal Investigator: Hristos Kaimakliotis, MD


Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.